Percutaneous transcatheter closure of the native aortic valve to treat de novo aortic insufficiency after implantation of a left ventricular assist device

摘要

A 54-year-old female with a HeartMate II (Thoratec, Pleasanton, California) left ventricular assist device (LVAD) presented 3 months after implantation with new-onset severe aortic insufficiency (AI) and cardiogenic shock. A re-operation for surgical aortic valve closure was toohigh risk, so the patient was referred for percutaneous therapy